NXTC Investor relations

NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Published September 04, 2025 at 11:00 AM

(NASDAQ:NXTC) BELTSVILLE, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference in New York City on Monday, September 8th, at 4:00 pm ET.